Sort
15,842 grants matching “pancreatic cancer”
Function of IL35+ B cells in pancreatic cancer
$394,032Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2023 · CA
A systems-metabolism approach to identify mitochondria-dependent vulnerabilities in colorectal cancer
$393,941David Francis Kashatus · University Of Virginia · U54 · FY2022 · CA
N-3 Fatty Acid-Induced Akt Suppression: Chemoprevention for Pancreatic Neoplasia
$393,779Paul Joseph Grippo · University Of Illinois At Chicago · R01 · FY2014 · CA
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma
$393,750Kenneth L Pitter · Ohio State University · DP5 · FY2025 · OD
Immune Activating CAR-Modified Antigen Presenting Cells
$393,750Carl Deselm · Washington University · DP5 · FY2021 · OD
Immune Activating CAR-Modified Antigen Presenting Cells
$393,750Carl Deselm · Washington University · DP5 · FY2022 · OD
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma
$393,750Kenneth L Pitter · Ohio State University · DP5 · FY2024 · OD
Immune Activating CAR-Modified Antigen Presenting Cells
$393,750Carl Deselm · Washington University · DP5 · FY2020 · OD
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma
$393,750Kenneth L Pitter · Ohio State University · DP5 · FY2023 · OD
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma
$393,750Kenneth L Pitter · Ohio State University · DP5 · FY2021 · OD
Discovering Spatial Mechanisms Regulating Metastatic Invadopodia in PDAC
$393,750Richard L. Klemke · University Of California, San Diego · R01 · FY2020 · CA
Cellular phenotypic heterogeneity and resistance to radiotherapy in pancreatic adenocarcinoma
$393,750Kenneth L Pitter · Ohio State University · DP5 · FY2022 · OD
Micro Ultrasound Scanner to Track Tumor Models
$393,698Kenneth P Olive · Columbia University Health Sciences · S10 · FY2011 · RR
PQ6: Lipocalin-2 as a therapeutic target for prevention of cancer cachexia
$393,676Daniel L Marks · Oregon Health & Science University · R01 · FY2021 · CA
G-Quadruplex-Mediated Transcriptional Regulation of PDGFR-??
$393,649Laurence H Hurley · University Of Arizona · R01 · FY2010 · CA
Project 1: Isolation Chemistry of Plants and U.S. Lichens and Biological Evaluation
$393,454Alan Douglas Kinghorn · Ohio State University · P01 · FY2025 · CA
PROTACs for pancreatic cancer therapy
$393,400Amarnath Natarajan · University Of Nebraska Medical Center · R21 · FY2020 · CA
Ferroptosis, Cellular Metabolism, and Cancer
$393,352Xuejun Jiang · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
$393,213James P Quigley · Scripps Research Institute, The · R01 · FY2009 · CA
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
$393,213James P Quigley · Scripps Research Institute, The · R01 · FY2010 · CA
A Cellular and Molecular Analysis of the Intravasation Step in Tumor Metastasis
$393,213James P Quigley · Scripps Research Institute, The · R01 · FY2008 · CA
The RAS and P13K Pathways in Pancreatic Adenocarcinoma
$393,191Lewis C Cantley · Dana-Farber Cancer Inst · P01 · FY2010 · CA
Matricellular proteins of the CNN family as regulators of tumor-induced cachexia
$393,162Sarah M Judge · University Of Florida · R01 · FY2023 · CA
Targeting metabolic stress to induce pancreatic tumor cell death
$393,143Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Common Genetically Altered Pathways as Targets for Therapy in Pancreatic Cancer
$392,993Agnieszka Witkiewicz · Roswell Park Cancer Institute Corp · R01 · FY2018 · CA